| Nancy Ann Becker, DO | |
|
1427 Jefferson Ave, Suite 101, Enumclaw, WA 98022-3649 | |
| (360) 825-4466 | |
| (360) 825-2064 |
| Full Name | Nancy Ann Becker |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 43 Years |
| Location | 1427 Jefferson Ave, Enumclaw, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679582654 | NPI | - | NPPES |
| 1067636 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | OP00001317 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Nose Throat Facial Plastic Surgery And Allergy Of Western Wa | 5395842686 | 5 |
| Muckleshoot Indian Tribe | 5092724286 | 6 |
News Archive
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
IpAuctions, Inc. will auction the worldwide biotherapeutic patents previously owned by Cell Works Inc., a Maryland-based biotech company, and acquired by CellPoint Diagnostics, Inc., based in Mountain View, Calif. These patents primarily consist of organ-targeted drug delivery systems to combat liver disease.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
UMD researchers are connecting climate change to urban and suburban stormwater management, with the ultimate goal of increasing resiliency to major storm events.
Thanks to a $1 million grant from the U.S. Department of Health and Human Services, San Diego State University and the SDSU-Imperial Valley campus are working to create a larger pool of diverse baccalaureate prepared nurses to serve the largely Hispanic population of Imperial County.
› Verified 5 days ago
| Entity Name | Ear Nose Throat Facial Plastic Surgery And Allergy Of Western Wa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346493806 PECOS PAC ID: 5395842686 Enrollment ID: O20070522000095 |
News Archive
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
IpAuctions, Inc. will auction the worldwide biotherapeutic patents previously owned by Cell Works Inc., a Maryland-based biotech company, and acquired by CellPoint Diagnostics, Inc., based in Mountain View, Calif. These patents primarily consist of organ-targeted drug delivery systems to combat liver disease.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
UMD researchers are connecting climate change to urban and suburban stormwater management, with the ultimate goal of increasing resiliency to major storm events.
Thanks to a $1 million grant from the U.S. Department of Health and Human Services, San Diego State University and the SDSU-Imperial Valley campus are working to create a larger pool of diverse baccalaureate prepared nurses to serve the largely Hispanic population of Imperial County.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Ann Becker, DO 1427 Jefferson Ave, Suite 101, Enumclaw, WA 98022-3649 Ph: (360) 825-4466 | Nancy Ann Becker, DO 1427 Jefferson Ave, Suite 101, Enumclaw, WA 98022-3649 Ph: (360) 825-4466 |
News Archive
Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
IpAuctions, Inc. will auction the worldwide biotherapeutic patents previously owned by Cell Works Inc., a Maryland-based biotech company, and acquired by CellPoint Diagnostics, Inc., based in Mountain View, Calif. These patents primarily consist of organ-targeted drug delivery systems to combat liver disease.
Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.
UMD researchers are connecting climate change to urban and suburban stormwater management, with the ultimate goal of increasing resiliency to major storm events.
Thanks to a $1 million grant from the U.S. Department of Health and Human Services, San Diego State University and the SDSU-Imperial Valley campus are working to create a larger pool of diverse baccalaureate prepared nurses to serve the largely Hispanic population of Imperial County.
› Verified 5 days ago